Stock Screener App

Gratuito -

Installare

1.38

3.76% 0.05

Inmed Pharmaceuticals Inc (INM)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Inmed Pharmaceuticals Inc Borsa (INM) Ultime notizie

InMed (INM) Q3 2025 Results: The Latest Report Adds New Financial Reference Points at the Close; Session Move: Shares Move 0.63% Lower in the Current UpdateEarnings Growth Forecast - vinanet.vn

InMed (INM) Session: Adds 0.63% to Close at $1.60 in Latest Trading; Current Setup: Traders Can Monitor the $1.52-$1.68 RangeVolatility Skew - vinanet.vn

InMed Pharmaceuticals (INM) Holds Above Support After 2.8% GainCash Secured Put - vinanet.vn

INM Q3 2025 Earnings: Net Loss of $1.94 Per Share; Stock Rises 2.8%One-Time Gain Impact - vinanet.vn

InMed Pharmaceuticals (INM) investor reports 4.2% beneficial stake in 137,634 shares - Stock Titan

Inmed Pharmaceuticals Stock Price Forecast. Should You Buy INM? - StockInvest.us

INM Q3 2025 Earnings: Net Loss of $1.94 Per Share Reflects Ongoing Biopharmaceutical InvestmentRevenue Breakdown Analysis - Vinanet

INM Q3 2025 Earnings: Net Loss of $1.94 Per Share ReportedFinancial Data - Vinanet

InMed Pharmaceuticals (INM) Rises 3.55% to $1.46 as Buyers Defend Key SupportMA Crossover - dars.gov.et

InMed Pharmaceuticals Inc (INM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

InMed Pharmaceuticals (INM) Slips 6% to $1.40 as Support Level Comes into FocusIchimoku Kumo Twist - dars.gov.et

InMed Pharmaceuticals (INM) Rises 2.40% as Shares Approach Key $1.58 ResistanceSector Leader Stocks - vinanet.vn

INM Q3 2025 Earnings: Net Loss of $1.94 Per Share Reflects Ongoing Clinical InvestmentNet Profit Margin - vinanet.vn

INM Q3 2025 Earnings: Narrowing Losses and Cautious Pipeline ProgressRevenue Growth Report - vinanet.vn

InMed Pharmaceuticals Inc (INM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

InMed Pharmaceuticals Inc (INM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

InMed Pharmaceuticals Inc (INM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

InMed Pharmaceuticals Inc (INM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

InMed Pharmaceuticals Inc (INM) Institutional Confidence - TradingKey

INM|InMed Pharmaceuticals Inc|Price:1.580|Chg%:-0.130 - TradingKey

TradingKey - TradingKey

INM|InMed Pharmaceuticals Inc|Price:1.670|Chg%:-0.040 - TradingKey

InMed Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:INM - TradingView

InMed Pharmaceuticals Inc (INM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

ADAR1 Capital Management, LLC Acquires Additional Shares in InMed Pharmaceuticals Inc - GuruFocus

INM Q3 2025 Earnings: InMed Pharmaceuticals Reports Net Loss of $1.94 Per Share as Stock Rises 11.45%Guidance Accuracy Score - dars.gov.et

Mentari Therapeutics Raises $200 Million for Migraine Prevention Pipeline Ahead of InMed Merger - Minichart

InMed Pharmaceuticals (INM) plans Mentari merger with $490M financings - Stock Titan

InMed to Merge with Mentari as Mentari Secures $200M Pre-Closing Financing - TradingView

InMed Pharmaceuticals Merger Partner Raises $200 Million To Boost Migraine Pipeline - Benzinga

INM Stock Whipsaws As InMed Refines Mentari Merger Terms - StocksToTrade

InMed Pharmaceuticals (NASDAQ:INM) climbs after $200 million Mentari infusion strengthens merger funding calculations - TechStock²

INM Stock Jumps As Traders Digest Amended Mentari Merger - StocksToTrade

INM Stock Jumps As Amended Mentari Merger Takes Shape - timothysykes.com

Morning Market Movers: INM, INLF, SXTC, ADVB See Big Swings - RTTNews

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline - PR Newswire

InMed Pharmaceuticals Inc (NASDAQ: INM) Share Price, INM Stock News, INM Share Price & Updates - Kalkine

InMed (NASDAQ: INM) outlines Mentari merger structure and names new CEO - Stock Titan

InMed Pharmaceuticals (INM) Gains 1.3% as Stock Approaches Key Resistance LevelForce Index - dars.gov.et

ADAR1 Capital acquires 1,000 InMed common shares worth $1,555 - Bitget

InMed Pharmaceuticals (INM) holder buys 1,000 common shares via ADAR1 - Stock Titan

Vivo Opportunity reports USD 32,319 purchase of InMed common shares - Bitget

Vivo Opportunity funds add 20,546 InMed Pharmaceuticals (INM) shares - Stock Titan

InMed Pharmaceuticals(INM) Stock Options Chain | Quotes & News - Moomoo

InMed Pharmaceuticals Company Profile & Introduction - Moomoo

InMed Pharmaceuticals and Mentari Therapeutics Amend Merger Agreement and File Registration Statement for Migraine Therapy Deal 1 – Minichart - Minichart

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

InMed amends merger terms, advances Mentari transition - TipRanks

InMed Pharmaceuticals (Nasdaq: INM) refines structure of planned Mentari merger - Stock Titan

InMed Pharmaceuticals Updates Mentari Merger Terms, Adding PIPE Option and Confirming Tax Reorganization - TradingView

InMed Pharmaceuticals (NASDAQ: INM) clarifies Mentari merger structure and targets Q4 2026 closing - Stock Titan

Enterprise value to EBIT forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView

InMed Pharmaceuticals Amends Deal With Mentari Therapeutics - Moomoo

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-NIMU, INM, OLN, and HUN - The Malaysian Reserve

InMed Pharmaceuticals (INM) Moves Forward with Merger Agreement Amendments - GuruFocus

InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 - TMX Newsfile

InMed Pharmaceuticals (INM) Stages 7% Advance: Testing Key Resistance LevelPut Dominated - DonanımHaber

InMed Pharmaceuticals และ Mentari Therapeutics ประกาศแก้ไขข้อตกลงการควบรวมกิจการ พร้อมยื่นแบบแสดงรายการข้อมูลการจดทะเบียน (Registration Statement) ตามแบบ Form S-4 - Moomoo

InMed Pharmaceuticals (INM) Slips 1.89% as Shares Test Key Support at $1.48Counter Trend Trade - dars.gov.et

INMInMed Pharmaceuticals Inc Forecast, Target Price - Finviz

ALKS

$46.10

1.66%

RDY

$11.97

0.50%

ELAN

$24.50

0.33%

NBIX

$155.64

1.71%

VTRS

$16.88

0.35%

UTHR

$487.61

0.54%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters